v3.26.3
Shareholders’ Deficit (Details Narrative) - USD ($)
6 Months Ended
Jul. 31, 2026
Feb. 20, 2026
Jan. 31, 2026
Sep. 29, 2025
Jul. 31, 2026
Subsidiary, Sale of Stock [Line Items]          
Ordinary stock, shares authorized 500,000,000   500,000,000   500,000,000
Ordinary shares, par value $ 0.0001   $ 0.0001   $ 0.0001
Shares issued   1,150,000   1,725,000 2,875,000
Proceeds from issuance of ordinary shares       $ 25,000  
Share price, per share $ 0.0087     $ 0.0145 $ 0.0087
Ordinary stock, shares issued [2] 3,001,250 [1]   2,875,000   3,001,250 [1]
Ordinary stock, shares outstanding [2] 3,001,250 [1]   2,875,000   3,001,250 [1]
Related Party [Member]          
Subsidiary, Sale of Stock [Line Items]          
Shares issued       2,875,000  
Share price, per share $ 12.00     $ 0.0087 $ 12.00
Ordinary stock, shares issued 2,625,000   2,875,000   2,625,000
Ordinary stock, shares outstanding 2,625,000   2,875,000   2,625,000
Over-Allotment Option [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of ordinary shares forfeited during the period 250,000 2,875,000 375,000    
Public Rights [Member]          
Subsidiary, Sale of Stock [Line Items]          
Ordinary stock, shares issued 10,500,000       10,500,000
Ordinary stock, shares outstanding 10,500,000       10,500,000
Private Rights [Member]          
Subsidiary, Sale of Stock [Line Items]          
Ordinary stock, shares issued 226,250       226,250
Ordinary stock, shares outstanding 226,250       226,250
[1] As a result of the partial exercise of the underwriters’ over-allotment option to purchase 500,000 Units, which closed on May 27, 2026, 125,000 of the 375,000 Founder Shares were no longer subject to forfeiture. The remaining 250,000 Founder Shares were forfeited for no consideration upon expiration of the unexercised portion of the over-allotment option in June 2026.
[2] Ordinary shares have been retroactively restated to reflect the issuance of an additional 1,150,000 Founder Shares to the Sponsor for no consideration on February 20, 2026, resulting in an aggregate of 2,875,000 Founder Shares held by the Sponsor (of which 1,725,000 Founder Shares were originally issued on September 29, 2025 for an aggregate purchase price of $25,000), including an aggregate of up to 375,000 Founder Shares that were subject to forfeiture to the extent the underwriters’ Over-Allotment Option was not exercised in full or in part (see Note 5).